KORU Medical Systems Stock

KORU Medical Systems FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of KORU Medical Systems (KRMD) as of Aug 16, 2026 is 17.82 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 26.66 % — a change of -33.14% (lower).

FCF Conversion

17.82 %

YoY

-33.14%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of KORU Medical Systems is 2026 17.82 % . FCF Conversion Rate (FCF/EBITDA) of KORU Medical Systems was 2025 26.66 % . It decreases by -33.14% lower compared to the previous year.
Access this data via the Eulerpool API

KORU Medical Systems Stock analysis

What does KORU Medical Systems do? Repro Med Systems Inc is a US-based company specializing in the development and manufacturing of medical devices for infusion therapy. The company was founded in 1980 by Edward L. Swanson and is headquartered in Chester, New York. Repro Med Systems Inc started as a small family business developing medical devices for reproductive medicine. Over the years, the company expanded and began focusing on other medical applications. In the 1990s, the company developed an innovative infusion pump system, later known as the "Freedom Syringe Infusion System." This system received numerous patents and proved to be a groundbreaking innovation in infusion therapy. Repro Med Systems Inc specializes in selling medical devices for infusion therapy. The company uses a direct sales model, allowing them to sell products directly to end customers. This enables the company to better understand customer needs and quickly respond to industry changes. Repro Med Systems Inc offers a variety of products for infusion therapy, including the "Freedom Syringe Infusion System," the "MRidium" infusion pump system, and the "Freo" intermittent dosing infusion pump system. The "Freedom Syringe Infusion System" is a portable infusion pump system that allows the administration of medications and fluids through a needleless disposable syringe. The system is easier to use than conventional infusion pumps and provides patients with more freedom and mobility during treatment. The "MRidium" infusion pump system has been specifically designed for use in magnetic resonance imaging (MRI). The system is immune to magnetic interference and can be used during an MRI examination to provide patients with infusions. The "Freo" intermittent dosing infusion pump system is a simple and reliable system that allows the administration of medications in variable doses. The system is ideal for pain management and enables patients to administer their medications quickly and easily. In conclusion, Repro Med Systems Inc is an innovative company specializing in the development and manufacturing of medical devices for infusion therapy. The company has experienced remarkable growth in recent years and is now a key player in the industry. With its focus on innovation and customer satisfaction, the company is expected to continue to be successful in the future. KORU Medical Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KORU Medical Systems stock

FCF Conversion Rate (FCF/EBITDA) of KORU Medical Systems is 17.82 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of KORU Medical Systems changed from 26.66 % to 17.82 %, representing a -33.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) KORU Medical Systems since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s KORU Medical Systems with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — KORU Medical Systems

All Key Metrics — KORU Medical Systems